| Citation: |
LI Xiaojie, YIN Guilin, DONG Yongqiang, ZHU Shuibo, ZHANG Xiaoming, JI Tao, XU Jiahang. Expressions of SFRP1 Gene Methylation and SFRP1 Protein in Lung Adenocarcinoma and Related Clinical Significance[J]. Cancer Research on Prevention and Treatment, 2017, 44(5): 320-323. DOI: 10.3971/j.issn.1000-8578.2017.05.002
|
To investigate the expression of SFRP1 gene methylation and SFRP1 protein in lung adenocarcinoma tissues.
There were 60 lung adenocarcinoma patients who underwent a completely surgical excision from May 2015 to May 2016. The expression of SFRP1 gene methylation, SFRP1 mRNA and SFRP1 protein in lung adenocarcinoma tissues and adjacent tissues were detected respectively by methylation specific PCR, real-time PCR and immunohistochemistry.
SFRP1 gene methylation rate was higher in tumor tissues than that in adjacent tissues (58.3% vs. 20.0%, P=0.001). The relative expression of SFRP1 mRNA in tumor tissues and adjacent tissues were (0.847±0.297) and (2.019±0.445) (P < 0.01). The positive expression rate of SFRP1 protein in tumor tissues was significantly lower than that in adjacent tissues (38.3%(23/60) vs. 83.3%(25/30), (P < 0.001)). SFRP1 protein expression was correlated with differentiation degree, clinical stage and lymph node metastasis (P < 0.05). SFRP1 gene methylation was closely correlated with SFRP1 protein expression deficiency in lung adenocarcinoma tissues (r=-0.585, P < 0.001).
The expression of SFRP1 gene methylation and protein are associated with the degree of differentiation and lymph node metastasis. The decrease of SFRP1 protein expression may be due to SFRP1 gene methylation.
| [1] |
Fossat N, Jones V, Khoo PL, et al.Stringent requirement of a proper level of canonical Wnt signalling activity for head formation in mouse embryo[J].Development, 2011, 138(4): 667-76. doi: 10.1242/dev.052803
|
| [2] |
朱智杰, 阮君山, 李尧, 等.Wnt信号通路诱导肿瘤细胞上皮-间质转化的研究进展[J].中国药理学通报, 2012, 28(7): 904-7. http://www.cnki.com.cn/Article/CJFDTOTAL-YAOL201207006.htm
Zhu ZJ, Ruan JS, Li X, et al.Research progress of Wnt signaling pathway induced EMT in tumor cells[J].Zhongguo Yao Li Xue Tong Bao, 2012, 28(7): 904-7. http://www.cnki.com.cn/Article/CJFDTOTAL-YAOL201207006.htm
|
| [3] |
Rawson JB, Manno M, Mrkonjic M, et al.Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients[J].Carcinogenesis, 2011, 32(5): 741-7. doi: 10.1093/carcin/bgr020
|
| [4] |
Jeong YJ, Jeong HY, Bong JG, et al.Low methylation levels of the SFRP1 gene are associated with the basal-ike subtype of breast cancer[J].Oncol Rep, 2013, 29(5): 1946-54. doi: 10.3892/or.2013.2335/download
|
| [5] |
Lin YW, Chung MT, Lai HC, et al.Methylation analysis of SFRP genes family in cervical adenocarcinoma[J].J Cancer Res Clin Oncol, 2009, 135(12): 1665-74. doi: 10.1007/s00432-009-0613-5
|
| [6] |
Ghoshal A, Ghosh SS.Expression, purification, and therapeutic implications of recombinant SFRP1[J].Appl Biochem Biotechnol, 2015, 175(4): 2087-103. doi: 10.1007/s12010-014-1354-8
|
| [7] |
Zhang H, Zhu YQ, Wu YQ, et al.Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectalcan[J].World J Gastroenterol, 2014, 20(20): 6329-35. doi: 10.3748/wjg.v20.i20.6329
|
| [8] |
Ricketts CJ, Hill VK, Linehan WM.Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project[J].PLoS One, 2014, 9(1): e85621. doi: 10.1371/journal.pone.0085621
|
| [9] |
Licchesi JD, Westra WH, Hooker CM, et al.Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung[J].Carcinogenesis, 2008, 29(5): 895-904. doi: 10.1093/carcin/bgn017
|
| [10] |
方汉林, 于在诚, 祝会斌.SFRP1基因甲基化及其蛋白在非小细胞肺癌组织中的表达[J].中国肿瘤外科杂志, 2012, 4(2): 95-8. http://www.cnki.com.cn/Article/CJFDTOTAL-ZLWK201202010.htm
Fang HL, Yu ZC, Zhu HB.Expression of SFRPl genemethylation and SFRPl protein in non-small cell lung cancer[J].Zhongguo Zhong Liu Wai Ke Za Zhi, 2012, 4(2): 95-8. http://www.cnki.com.cn/Article/CJFDTOTAL-ZLWK201202010.htm
|
| [11] |
Bremnes RM, Veve R, Gabrielson E, et al.High-throughput tissue micro-array analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer[J].J Clin Oncol, 2002, 20(10): 2417-28. doi: 10.1200/JCO.2002.08.159
|
| [12] |
Pirinen RT, Hirvikoski P, Johansson RT, et al.Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer[J].J Clin Pathol, 2001, 54(5): 391-5. doi: 10.1136/jcp.54.5.391
|
| [13] |
Taquchi YH, Iwadate M, Umeyama H.SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer[J].BMC Med Genomics, 2016, 9 Suppl 1: 28. https://www.researchgate.net/profile/Y_H_Taguchi/publication/306084951_SFRP1_is_a_possible_candidate_for_epigenetic_therapy_in_non-small_cell_lung_cancer/links/57b003ad08ae0101f1776d7f.pdf?origin=publication_list
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: